Skip to main content
Equibles
DBD $69.26 +1.61%
DBD logo
DBD · DIEBOLD NIXDORF, Inc
Track DBD — free

Use DBD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DBD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$69.26 +1.10 (+1.61%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.31B
Shares
33.95M
Volume · Oct 22 196.26K Avg daily vol (3M) 261.05K
All webcasts

Earnings call · FY2022 Q4

DIEBOLD NIXDORF, Inc (DBD) Q4 2022 Earnings Call

Concluded Feb 9, 2023
Feb 9, 2023 0 turns
Period
FY2022 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $968.80M -8.6% YoY
Gross margin · derived Q4 22.4% -2.0 pp YoY
Net income · derived Q4 -$149.30M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 9, 2023 10-K report Filed Mar 16, 2023 Company webcastOpen the original investor-relations page
Full-screen source Call document

DBD alerts

DIEBOLD NIXDORF, Inc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →